Pharmaceutical Chaperones and Proteostasis Regulators in the Therapy of Lysosomal Storage Disorders: Current Perspective and Future Promises

Different approaches have been utilized or proposed for the treatment of lysosomal storage disorders (LSDs) including enzyme replacement and hematopoietic stem cell transplant therapies, both aiming to compensate for the enzymatic loss of the underlying mutated lysosomal enzymes. However, these appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed, Fedah E., Al-Gazali, Lihadh, Al-Jasmi, Fatma, Ali, Bassam R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500627/
https://www.ncbi.nlm.nih.gov/pubmed/28736525
http://dx.doi.org/10.3389/fphar.2017.00448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500627/
https://www.ncbi.nlm.nih.gov/pubmed/28736525
http://dx.doi.org/10.3389/fphar.2017.00448

Ejemplares similares